Stemedica International Discovers Connection between Gut Microbiome and Alzheimer's Disease (AD)
A groundbreaking scientific article titled "Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota" was published 8 February 2017 in Scientific Reports, a Nature Research journal. The preclinical research was conducted at École Polytechnique…
Society for Neuroscience (SfN) Selects Stemedica International's Research as a Hot Topic
Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer's disease (AD), is pleased to announce it will share its latest preclinical data at the Society for Neuroscience 46th Annual Conference held from November 12-16…